Ocuphire Pharma (OCUP) Stock Chart & Stock Price History → Trump Asset Seizure Threat Alert: Could Your Savings Be Next? (From American Hartford Gold Group) (Ad) Free OCUP Stock Alerts $1.83 -0.11 (-5.67%) (As of 05/8/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Ocuphire Pharma Stock Price Performance5 Day Performance-8.04%1 Month Performance-1.61%3 Month Performance-30.15%6 Month Performance-36.46%Year-To-Date Performance-39.20%1 Year Performance-68.45% Receive OCUP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ocuphire Pharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad American Hartford Gold GroupTrump Asset Seizure Threat Alert: Could Your Savings Be Next?Trump Asset Seizures Threat A Warning For 401K Owners?Request Your FREE WEALTH PROTECTION GUIDE OCUP Stock Chart for Thursday, May, 9, 2024 OCUP Chart by TradingView Ocuphire Pharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$1.94$1.83-5.67%$1.95$1.81165,995 shs$46.87 million05/07/2024$2.01$1.94-3.48%$2.06$1.93185,957 shs$49.68 million05/06/2024$1.99$2.01+1.01%$2.11$2.01228,426 shs$51.48 million05/03/2024$1.85$1.99+7.57%$2.04$1.86350,267 shs$50.96 million05/02/2024$1.64$1.85+12.80%$1.99$1.65663,090 shs$47.38 million05/01/2024$1.59$1.64+3.47%$1.66$1.5944,031 shs$40.69 million Get the Latest News and Ratings for OCUP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ocuphire Pharma and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$1.65$1.59-3.94%$1.69$1.5736,476 shs$39.33 million04/29/2024$1.61$1.65+2.48%$1.71$1.6182,363 shs$40.94 million04/26/2024$1.54$1.61+4.89%$1.63$1.55113,205 shs$39.94 million04/25/2024$1.53$1.54+0.33%$1.56$1.50110,604 shs$38.08 million04/24/2024$1.54$1.53-0.65%$1.56$1.5089,829 shs$37.96 million04/23/2024$1.51$1.54+1.99%$1.58$1.51140,451 shs$38.21 million04/22/2024$1.66$1.51-8.76%$1.64$1.50379,168 shs$37.46 million04/19/2024$1.67$1.66-0.90%$1.69$1.59234,995 shs$41.06 million04/18/2024$1.74$1.67-4.02%$1.78$1.67239,603 shs$41.43 million04/17/2024$1.74$1.74$1.78$1.7492,407 shs$43.17 million04/16/2024$1.76$1.74-1.14%$1.79$1.71113,668 shs$43.18 million04/15/2024$1.84$1.76-4.35%$1.86$1.74196,987 shs$43.67 million04/12/2024$1.79$1.84+2.79%$1.89$1.71467,162 shs$45.65 million04/11/2024$1.86$1.79-3.76%$1.87$1.77235,100 shs$44.41 million04/10/2024$1.86$1.86$1.91$1.83172,741 shs$46.15 million04/09/2024$1.83$1.86+1.64%$1.89$1.8394,807 shs$46.15 million04/08/2024$1.91$1.83-4.19%$1.93$1.83284,244 shs$45.40 million04/05/2024$1.88$1.91+1.60%$1.94$1.83272,155 shs$47.39 million04/04/2024$1.94$1.88-3.09%$2.04$1.86339,965 shs$46.64 million04/03/2024$2.18$1.94-11.01%$2.22$1.90476,694 shs$48.13 million04/02/2024$2.23$2.18-2.24%$2.34$2.14723,399 shs$54.09 million04/01/2024$2.01$2.23+10.95%$2.23$2.02680,194 shs$55.33 million03/29/2024$2.01$2.01$2.03$1.99124,374 shs$49.87 million03/28/2024$2.02$2.01-0.50%$2.03$1.99121,779 shs$49.87 million03/27/2024$2.03$2.02-0.49%$2.05$1.96215,412 shs$50.12 million03/26/2024$1.96$2.03+3.57%$2.03$1.96233,597 shs$50.36 million03/25/2024$2.03$1.96-3.45%$2.12$1.95218,349 shs$48.63 million03/22/2024$2.09$2.03-2.87%$2.11$2.02130,338 shs$50.36 million03/21/2024$1.98$2.09+5.56%$2.11$2.04217,169 shs$51.85 million03/20/2024$1.91$1.98+3.66%$1.98$1.90125,981 shs$49.12 million03/19/2024$1.93$1.91-1.04%$1.97$1.8787,111 shs$47.39 million03/18/2024$1.90$1.93+1.58%$1.99$1.87194,796 shs$47.88 million03/15/2024$1.89$1.90+0.53%$1.99$1.87250,390 shs$47.14 million03/14/2024$2.05$1.89-7.80%$2.08$1.85465,695 shs$46.89 millionThe 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. 03/13/2024$2.14$2.05-4.21%$2.18$2.03208,348 shs$50.86 million03/12/2024$2.09$2.14+2.39%$2.18$2.06184,690 shs$48.45 million03/11/2024$1.99$2.09+5.03%$2.17$2.00328,010 shs$47.32 million03/08/2024$2.38$1.99-16.39%$2.35$1.93818,734 shs$45.05 million03/07/2024$2.42$2.38-1.65%$2.48$2.34165,803 shs$53.88 million03/06/2024$2.43$2.42-0.41%$2.50$2.42121,221 shs$54.79 million03/05/2024$2.47$2.43-1.62%$2.47$2.39143,458 shs$55.02 million03/04/2024$2.53$2.47-2.37%$2.51$2.43174,991 shs$55.92 million03/01/2024$2.54$2.53-0.39%$2.57$2.44176,943 shs$57.28 million02/29/2024$2.59$2.54-1.93%$2.60$2.51111,277 shs$57.51 million02/28/2024$2.64$2.59-1.89%$2.65$2.57117,670 shs$58.64 million02/27/2024$2.53$2.64+4.35%$2.64$2.53222,433 shs$59.76 million02/26/2024$2.50$2.53+1.20%$2.59$2.46183,684 shs$57.28 million02/23/2024$2.50$2.50$2.53$2.4685,759 shs$56.60 million02/22/2024$2.45$2.50+2.04%$2.55$2.41163,170 shs$56.60 million02/21/2024$2.58$2.45-5.04%$2.60$2.34236,937 shs$55.47 million02/20/2024$2.63$2.58-1.90%$2.63$2.55116,517 shs$58.41 million02/19/2024$2.63$2.63$2.71$2.5875,400 shs$59.54 million02/16/2024$2.65$2.63-0.75%$2.71$2.5875,092 shs$59.54 million02/15/2024$2.60$2.65+1.92%$2.65$2.60110,029 shs$60.00 million02/14/2024$2.57$2.60+1.17%$2.63$2.52148,602 shs$58.86 million02/13/2024$2.66$2.57-3.38%$2.67$2.52169,729 shs$58.19 million02/12/2024$2.62$2.66+1.53%$2.77$2.60286,892 shs$60.22 million02/09/2024$2.52$2.62+3.97%$2.65$2.54116,992 shs$59.32 million02/08/2024$2.48$2.52+1.61%$2.60$2.45288,269 shs$57.05 million Related Companies: Unicycive Therapeutics Stock Price Chart Lexaria Bioscience Stock Price Chart Xilio Therapeutics Stock Price Chart Apollomics Stock Price Chart ProMIS Neurosciences Stock Price Chart Cara Therapeutics Stock Price Chart Immuneering Stock Price Chart Bolt Biotherapeutics Stock Price Chart Marker Therapeutics Stock Price Chart Rockwell Medical Stock Price Chart Receive OCUP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ocuphire Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OCUP) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetry348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm PressGlobal crypto currency reset (41 major banks signed up)Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocuphire Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.